EUVIMEDEUVIMED entdecken
Crossref

Treatment nonresponders in lupus nephritis characteristically exhibit persistent type I interferon signalling in monocytes: a longitudinal single-cell transcriptomic analysis

Woo-Joong Kim, Hye-Soon Lee, So-Young Bang, Young Bin Joo, Bo-Kyeong Kang, Mimi Kim, Hyunsung Kim, Sung Yul Park, Woong-Yang Park, Eui-Cheol Shin, Sang-Cheol Bae

Annals of the Rheumatic Diseases · 2026

DOI: 10.1016/j.ard.2025.12.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2026. Verfasst von Woo-Joong Kim und 10 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea; Department of Rhe…. Hauptthemen laut MEDLINE: Lupus Nephritis, Interferon Type I, Monocytes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: We aimed to characterise the dynamic transcriptional changes associated with treatment responses in lupus nephritis (LN) through longitudinal single-cell RNA sequencing analysis of peripheral blood mononuclear cells (PBMCs) during standard-of-care induction therapy. METHODS: We leveraged the Korean Unlimited multi-Dimensional Omics research in Systemic lupus erythematosus cohort, comprising patients with biopsy-proven active proliferative LN. Single-cell RNA sequencing of PBMCs was conducted at baseline and subsequently at 3, 6, and 12 months following initiation of therapy (n = 10). For validation purposes, bulk RNA sequencing of monocytes was performed in an independent patient group at baseline and at 3 months (n = 13). Renal response was classified as complete response or nonresponse at 12 months according to predefined criteria. RESULTS: In single-cell RNA sequencing analysis of patients with LN, the myeloid cell population-particularly classical and intermediate monocytes-demonstrated the highest number of differentially expressed genes following induction therapy. Weighted gene coexpression network analysis identified distinct gene modules closely associated with treatment responses. Complete responders exhibited progressive suppression of type I interferon (IFN-I) signalling, whereas nonresponders maintained persistent IFN-I-driven gene expression characterised by sustained inflammatory features. Bulk RNA sequencing of monocytes from an independent group of patients with LN confirmed that 6 IFN-I-responsive genes (IRF7, ISG15, LY6E, IFI44, IFI44L, and IFI6) were significantly downregulated by 3 months in complete responders, but not in nonresponders. This gene signature correlated with both proteinuria and disease activity scores. CONCLUSIONS: This study demonstrates that persistent IFN-I-driven gene expression in monocytes characterises treatment resistance in LN. Our findings suggest that early transcriptional profiling may enable timely identification of nonresponders and warrant further investigation in larger, independent cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus NephritisInterferon Type IMonocytesHumansFemaleAdultMaleSignal TransductionGene Expression ProfilingLongitudinal StudiesSingle-Cell AnalysisSequence Analysis, RNATranscriptomeMiddle AgedTreatment OutcomeLeukocytes, Mononuclear

Substanzen

Interferon Type I

Autor:innen und Institutionen

  • Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea; Department of Rheumatology, Chung-Ang University Hospital, Seoul, Republic of Korea.
  • Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea; Hanyang University Institute for Rheumatology Research, Seoul, Republic of Korea; Hanyang Institute of Bioscience…
  • Department of Radiology, Hanyang University College of Medicine, Seoul, Republic of Korea.
  • Department of Pathology, Hanyang University College of Medicine, Seoul, Republic of Korea.
  • Department of Urology, Hanyang University College of Medicine, Seoul, Republic of Korea.
  • Samsung Genome Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Kim, W. J., Lee, H. S., Bang, S. Y., Joo, Y. B., Kang, B. K., Kim, M., Kim, H., Park, S. Y., Park, W. Y., Shin, E. C., & Bae, S. C. (2026). Treatment nonresponders in lupus nephritis characteristically exhibit persistent type I interferon signalling in monocytes: a longitudinal single-cell transcriptomic analysis. Annals of the Rheumatic Diseases. https://doi.org/10.1016/j.ard.2025.12.002

Vancouver

Kim WJ, Lee HS, Bang SY, Joo YB, Kang BK, Kim M, et al. Treatment nonresponders in lupus nephritis characteristically exhibit persistent type I interferon signalling in monocytes: a longitudinal single-cell transcriptomic analysis. Annals of the Rheumatic Diseases. 2026. doi:10.1016/j.ard.2025.12.002

BibTeX
@article{Kim2026,
  author = {Kim, Woo-Joong and Lee, Hye-Soon and Bang, So-Young and Joo, Young Bin and Kang, Bo-Kyeong and Kim, Mimi and Kim, Hyunsung and Park, Sung Yul and Park, Woong-Yang and Shin, Eui-Cheol and Bae, Sang-Cheol},
  title = {Treatment nonresponders in lupus nephritis characteristically exhibit persistent type I interferon signalling in monocytes: a longitudinal single-cell transcriptomic analysis},
  journal = {Annals of the Rheumatic Diseases},
  year = {2026},
  doi = {10.1016/j.ard.2025.12.002}
}
Kostenlos starten →